The conversion of oestriol into 2-hydroxyoestriol and 2-methoxyoestriol by rat-and rabbit-liver slices described in the preceding paper indicated a new metabolic pathway for oestrogens in vitro. The results suggested that the oestriol was hydroxylated in the 2 position and this hydroxyl group was then methylated to form 2-methoxyoestriol.
Department of Biochemistry, Univer8ity of Edinburgh (Received 2 September 1960) The conversion of oestriol into 2-hydroxyoestriol and 2-methoxyoestriol by rat-and rabbit-liver slices described in the preceding paper indicated a new metabolic pathway for oestrogens in vitro. The results suggested that the oestriol was hydroxylated in the 2 position and this hydroxyl group was then methylated to form 2-methoxyoestriol.
A number of papers (reviewed by Grant, 1956a) have described the hydroxylation of neutral steroids in vitro, and Mueller & Rumney (1957) have studied the 6'oc'-hydroxylation of oestradiol-17,B by rat-and mouse-liver microsomal preparations. These hydroxylations all appear to require molecular oxygen and reduced pyridine nucleotide. The 2-hydroxylation of oestriol represents a major difference from these reactions in that the hydroxyl group is entering a benzenoid ring structure. Brodie et at. (1955) have shown that the hydroxylation of aromatic compounds such as acetanilide also requires oxygen and reduced triphosphopyridine nucleotide, so that some similarity exists between the hydroxylation of aromatic and aliphatic compounds. However, Kaufman (1959) has shown that a tetrahydrofolic acid derivative is required for the conversion of phenylalanine into tyrosine, whereas this vitamin has no effect on the 11 plhydroxylation of 1l-deoxycorticosterone (Tomkins, Curran & Michael, 1958) .
The O-methylation of catechols is well known (Axelrod & Tomchick, 1958; Pellerin & D'Ionio, 1958) , and, like N-methylation (Cantoni, 1951; Cantoni & Vignos, 1954) , the methyl group can be derived from methionine via S-adenosylmethiomine.
This paper describes the cofactor requirements of the rat-liver 2-methoxylating system.
EXPERIMENTAL Enzyme preparation8 and methods
The rats were killed by a blow on the back of the neck. Liver and kidney homogenates were prepared by mincing the tissue in a Latapie mincer to remove connective tissue and then homogenizing with cold 0-25M-sucrose in a glass homogenizer fitted with a nylon pestle. The ovaries were disrupted in a 0-8 cm. x 15 cm. glass tube with a handoperated metal plunger; usually, 20% (w/v) homogenates were used. The uteri were slit longitudinally and the inside surface was blotted dry with filter paper. They were then cut into small pieces and finely minced with a Mickle automatic slicer. This brei was added to the appropriate volume of 0 25M-sucrose to give a 20% (w/v) suspension.
When required, the cell debris and nuclei were removed by centrifuging for 10 min. at 700g at 00 in a MSE refrigerated centrifuge and the mitochondria by centrifuging for 10 min. at 7000g. The 7000g supernatant fraction was usually obtained by centrifuging the whole homogenate for 10 min. at 7000g. The 105000g supernatant was separated from the microsomes by centrifuging the 7000g fraction for 30 min. at 105000g in a preparative Spinco model L centrifuge. The microsomes were suspended in 0-25M-sucrose by gentle homogenization with a glass ball so that 1 ml. of the suspension was equivalent to 1 ml. of homogenate (equivalent to 200 mg. wet wt. of original tissue).
Duplicate incubations were carried out in glass-stoppered test tubes and each experiment was repeated at least once.
The extraction and estimation of steroids were carried out as described in the preceding paper (King, 1961) except that the alumina-chromatography step was omitted in the experiments in which 2-methoxyoestriol was not estimated. By this modified method 80% recoveries of oestriol could be obtained regularly.
The Fast Black Salt K (diazotized p-nitrophenylazodimethoxyaniline) derivatives were prepared by the method of Heftmann (1950) . The Girard reaction was carried out as described in the preceding paper. The sodium borohydride reduction was carried out by dissolving the dry material in 1 ml. of methanol and adding 2 mg. of sodium borohydride (British Drug Houses Ltd.) . This solution stood at room temperature for 1 hr. and was then diluted with 10 ml. of 2N-HCI plus 39 ml. of water. The resultant solution was extracted three times with portions (50 ml.) of ether and the ether washed twice with 20 ml. of water. The ether extract was evaporated to dryness under vacuum.
Material8
Diphosphopyridine nucleotide (DPN) and barium glucose 6-phosphate were obtained from C. F. Boehringer und Sohne (GmbH., Mannheim, Germany). Sodium glucose 6-phosphate solutions were prepared from the barium salt by precipitating the barium with the calculated amount of sodium sulphate. Calcium lactate was kindly donated by Dr J. K. Grant and the sodium salt prepared from this by addition of the calculated amount of sodium oxalate.
Triphosphopyridine nucleotide (TPN), glucose 6-phosphate dehydrogenase and the sodium salt of adenosine triphosphate (ATP) were purchased from the Sigma Chemical Co.
(St Louis, Mo., U.S.A.). L-Methionlne and folic acid were bought from British Drug Houses Ltd. Dihydrofolic acid was kindly prepared by Dr E. Brode by the method of Futterman (1957) . Tetrahydrofolic acid was prepared by catalytic hydrogenation of folic acid. Adams platinum oxide catalyst (Johnson, Matthey and Co.) (30 mg.) was suspended in 10 ml. of acetic acid and hydrogenated for 3 hr. at room temperature with gentle shaking. Folic acid (100 mg.) was then added and the shaking continued until the yellow suspension changed to a green solution. The catalyst was removed by centrifuging and the tetrahydrofolic acid precipitated with 100 ml. of dry ether. The tetrahydrofolic acid was centrifuged off and rapidly washed twice with portions (50 ml.) of dry ether. The whitish precipitate was dried in vacuo and stored under nitrogen in the dark at -17°.
In addition to the steroids mentioned in the preceding paper, the stilboestrol (3:4-di-p-hydroxyphenylhex-3-ene) and 17oa-ethynyloestradiol-17, (17oC-ethynyloestra-1:3:5-triene-3:17,f-diol) were gifts fromDr G. S. Boyd. The oestriol was added to the incubation tubes as a solution in propylene glycol.
Ether (A.R. grade) was distilled once immediately before use. Other solvents and Celite were purified by the methods described by Bauld (1953) .
RESULTS
Cofactor requirements for the formation of 2-methoxyoe8triol by liver homogenate8 Magnesium ions, ATP, L-methionine, DPN and TPN were required for the optimum conversion of oestriol into 2-methoxyoestriol. The pyridine nucleotide requirements of this reaction are shown in Table 1 ; in the absence of DPN and TPN, the amount of oestriol metabolized is small and very little, if any, 2-hydroxyoestriol is produced. Although the addition of oxidizable substrates (lactate and glucose 6-phosphate) has very little effect, this is probably due to the presence of endogenous substrates which can reduce DPN and TPN, as the experiment described in Table 7 indicates that the reduced form is required for the 2-hydroxylation reaction. The effect of adding Mg2' ions, ATP and Lmethionine is shown in Table 2 . No other methyl donors were tested. These three cofactors have a marked effect on the production of 2-methoxyoestriol without altering the 2-hydroxylase activity. There is an absolute requirement for Mg2+ ions and L-methionine, whereas ATP has a pronounced stimulating effect. Dialysis of the homogenate against water at 00 for 18 hr. resulted in the complete loss of 2-hydroxylase activity, whereas preincubation of the homogenate for 30 min. at 370 resulted in the complete loss of methylating activity and a partial loss of the hydroxylase system (Table 3) .
Conversion of 2-hydroxyoestriol into 2-methoxyoestriol When 2-hydroxyoestriol was incubated with the optimum methoxylating system described in Table 2 there was a 20-30% conversion into 2-methoxyoestriol. The omission of DPN and TPN from the incubation medium had no effect, but in the absence of L-methionine no 2-methoxyoestriol was formed.
Substrate specificity of the 2-methoxylating system Two incubation tubes were set up for each compound to be tested. The complete methoxylating system described in Table 2 was added to tube A of each pair and L-methionine and ATP were omitted from the B series of tubes. The required compound (150 ,ug.) was added to the incubation tubes as a methanolic solution (0.025 ml.). Oestrone, oestradiol-17fl, 170x-ethynyloestradiol-17P and stilboestrol were used as substrates. After incubation for 1 hr. at 370 an ether extract was prepared as before and divided into three equal parts.
Part 1 was chromatographed on Whatman no. 1 paper in methanol-water-benzene-hexane Metabolism of oestriol by homogenates of different rat tissues Table 4 shows that the 2-hydroxylase is absent in rat kidney, uterus and ovary and that there is no sex difference in the liver 2-hydroxylase activity. The large amount of oestriol metabolized by kidney homogenates is partly explained by the formation of 16-oxo-oestradiol-17,B and 16-epioestriol (King, 1960) .
In this and subsequent experiments a simple potassium phosphate buffer was used instead of the potassium phosphate-magnesium chloride-potassium chloride solution employed in the methoxylation studies. When the phosphate buffer was replaced by an equal volume of 0 35M-2-amino-2-hydroxymethylpropane-1:3-diol(tris)-HCl, pH 7.4, no 2-hydroxyoestriol was formed. This hydroxylase systerm thus differs from the 1 1,-hydroxylase from ox-adrenal mitochondria which is more active in tris than in phosphate (Grant, 1956b of propylene glycol. Where stated, the following additions were also made: 1-4 ,umoles of TPN, 9 jLmoles of glucose 6-phosphate (G-6-P), 3 ,umoles of ATP, 2-5 itmoles of tetrahydrofolic acid, 0-07 unit of G-6-P dehydrogenase.
Final vol., 3 ml. Incubation was under 02 for 1 hr. at 37°.
2-Hvdroxv-
Additions TPN + G-6-P + G-6-P dehydrogenase (oestriol added just before extraction) TPN + G-6-P + G-6-P dehydrogenase TPN + G-6-P + G-6-P dehydrogenase + ATP Tetrahydrofolic acid +ATP Tetrahydrofolic acid + ATP + TPN Tetrahydrofolic acid + TPN + G-6-P + G-6-P dehydrogenase Tetrahydrofolic acid + TPN + G-6-P + G-6-P dehydrogenase + ATP fraction produced small amounts of 2-hydroxyoestriol (Table 7) . The best results were obtained on adding both ATP and tetrahydrofolic acid. The addition of a further 2-5 ,umoles of tetrahydrofolic acid 15 min. after the start of the incubation had no effect, which suggests that the folic acid derivative is not rate-limiting. Dihydrofolic acid can replace the tetrahydro compound (Table 8) but folic acid has only a small effect.
When the microsomes were dialysed against icecold water for 18 hr. or were washed with 0-25M-sucrose the 2-hydroxylase activity was lost, which suggested that some other cofactor, possibly a metal ion, is also required. This would explain the finding that only about half of the activity present in the 7000g supernatant could be recovered on further fractionation of this cell fraction.
Detection of other phenolic oestriol metabolites
In no case could any 6'ac'-hydroxyoestriol or 6-oxo-oestriol be detected. The addition of nicotinamide to the 7000g supernatant fraction resulted in the detection of two new phenolic metabolites. Both were ketonic, as determined by the Girard reaction. The less-polar compound had the same mobility as 16-oxo-oestradiol-17P in both formamide-chloroform and acetic acid-water-ethylene dichloride (70:30: 100, by vol.) systems. The other metabolite had the same mobility as oestriol in formamide-chloroform but it was slightly more polar than oestriol in acetic acid-water-ethylene dichloride. It was similar to 2-hydroxyoestriol in that it developed the Folin & Ciocalteu blue colour in the absence of alkali.
To characterize these compounds further, 200 ,ug. of oestriol was incubated under the conditions shown in Fig. 1 for 1 hr. The oestriol and 2-hydroxyoestriol were removed by Girard separation and the two ketonic metabolites were separated by paper chromatography with formamide-chloroform for 10 hr. This method of carrying out the Girard reaction does not result in the artifactual formation of 16-oxo-oestradiol-17, from 16o0-hydroxy-or 16fl-hydroxy-oestrone (Layne & Marrian, 1958) .
Half of the less-polar metabolite was converted into the Fast Black Salt K derivative. It had the same mobility as the Fast Black Salt K derivative of authentic 16-oxo-oestradiol-17P in ethanol-watertoluene-light petroleum (40-60°) (30:70:20: 10, by vol.) (Heftmann, 1950) . The other half was reduced with sodium borohydride. As judged from the chromatographic behaviour, the main reduction product was 16-epioestriol plus a trace of oestriol. Sodium borohydride reduction of 16-oxo-oestradiol-17P produces 90% of 16-epioestriol plus 10% of oestriol (Loke, 1958) . It thus seems probable that this metabolite is 16-oxo-oestradiol-17fi. Under these incubation conditions there was a 2-3 % conversion of oestriol into 16-oxo-oestradiol-17P. A similar yield was obtained when a 105OOOg supernatant fraction was used.
The yield of the more-polar metabolite was too small to allow further characterization. It may be 2-hydroxy-16-oxo-oestradiol-17, (2:3:17,B-trihydroxyoestra-1:3:5-triene-16-one). Another possibility is that it is the o-quinone derivative of 2-hydroxyoestriol, but this seems unlikely, as such a compound would strongly absorb u.v. light in the 240 mu region, whereas this metabolite does not. This would also seem to rule out a p-quinol derivative of the type discovered by Hecker & Mueller (1958) . DISCUSSION This work substantiates the conclusion made in the preceding paper that the conversion of oestriol into 2-methoxyoestriol proceeds via 2-hydroxyoestriol.
Like other steroid hydroxylases, the 2-hydroxylase requires a reduced pyridine nucleotide. Either DPN or TPN can be utilized, although the latter is more efficient at higher concentrations. The possibility cannot altogether be excluded that DPN is acting only indirectly via a transhydrogenation reaction. It is quite possible that the 7000g supernatant fraction is contaminated with mitochondria, which are known to possess a transhydrogenase (Humphrey, 1957) . This explanation would, however, seem unlikely, because, whereas exogenous pyridine nucleotide is required for the formation of 2-hydroxyoestriol, reasonable amounts are formed when DPN is added in the absence of TPN.
The function of the folic acid derivatives in this hydroxylation is not clear from these experiments. There are two possible explanations. The first is that a tetrahydrofolic acid derivative is the direct hydrogen donor and that the reduced pyridine nucleotide is acting only indirectly by reforming the tetrahydro compound. This is similar to the explanation given by Kaufman (1959) to account for his experiments on the conversion of phenylalanine into tyrosine. This would account for the relative effectiveness of folic acid, dihydrofolic acid and tetrahydrofolic acid in the presence of reduced TPN-producing system but does not explain the formation of 2-hydroxyoestriol in the absence of an exogenous folic acid derivative. This may be due to the presence of endogenous material in the microsomes, but as dialysis resulted in complete loss of hydroxylase activity this possibility could not be tested. The ineffectiveness of tetrahydrofolic acid in the absence ofreduced-TPN-producingsystem could be explained by the instability of this compound in solution in the presence of oxygen. It would, however, seem to rule out the possibility that the tetrahydrofolic acid and reduced TPN are donating hydrogen to a common hydrogen-accepting cofactor.
The other possibility is that reduced TPN is the direct hydrogen donor and that the added tetrahydrofolic acid is acting by re-forming reduced TPN. This explanation does not account for the fact that excess of glucose 6-phosphate and glucose 6-phosphate dehydrogenase are present in the incubation medium and that dihydrofolic acid is as effective as tetrahydrofolic acid in stimulating the hydroxylation reaction. It would be difficult to explain the effect of areduced-DPN-producing system by either of these hypotheses as all of the folic acid reductases so far isolated from normal mammalian tissues are TPN-specific. However, Scrimgeour & Huennekens (1960) claim to have detected a DPNspecific reductase in Ehrlich ascites-tumour cells.
If a folic acid derivative is required for 2-hydroxylation it would provide an interesting link between the observation that folic acid is needed for the oestrogen-stimulated growth of chicken oviduct (Hertz, 1948) and the fact that 2-and 4-hydroxyoestradiol-17B are the only compounds so far tested which have an effect on uterine protein metabolism in vitro (Mueller, 1955) .
The exact function of ATP in hydroxylation reactions is not certain. Hayano & Dorfman (1954) found that the DPN and ATP, previously thought to be required for 1ll-hydroxylation, could be replaced by TPN, which indicated that the ATP was converting the DPN into TPN. Similar results have been obtained with the adrenal-microsomal 21-hydroxylase (Ryan & Engel, 1957) . ATP stimulates the hydroxylation of acetanilide by liver microsomes in the presence of TPN plus a reduced TPN-producing system but had no effect when reduced TPN alone was added (Mitoma, Posner, Reitz & Udenfriend, 1956 ). It is difficult to reconcile the results given in the present paper with these explanations. If ATP is acting by phosphorylating DPN it should not stimulate the microsomal 2-hydroxylase in the absence of DPN. Also, in the experiments with the 7000g supernatant fraction, the ATP activation is independent of whether TPN alone or TPN plus DPN is added to the incubation medium. Under the conditions used in these experiments, the reduction of TPN is very rapid in the absence of ATP so it would seem unlikely that it is stimulating the production of reduced TPN. The fact that the 2-hydroxylating system is not affected by nicotinamide rules against pyridine nucleotide breakdown being a rate-limiting reaction, but the possibility cannot be eliminated that the ATP is stabilizing the pyridine nucleotides by some other mechanism. It is noteworthy that Kornberg (1950) has described an enzyme which catalyses the following reaction: ATP + nicotinamide mononucleotide = DPN + pyrophosphate.
The ATP could also be stimulating the reaction by activating a folic acid compound. Greenberg & Jaenicke (1957) The loss of activity on washing or dialysing the microsome fraction suggests that another cofactor, possibly a metal ion, is required.
As far as can be judged from the experiments with crude homogenates, the 2-hydroxylase does not appear to be very specific.
The small formation of 2-methoxyoestriol in the absence of ATP was rather unexpected. In other cases of 0-methylation (Axelrod & Tomchick, 1958; Pellerin & D'Ionio, 1958 ) the methyl group is derived from S-adenosylmethionine and it seems likely that the o-methyl group of 2-methoxyoestriol has a similar origin. The small amount of 2-methoxyoestriol formed in the absence of ATP is presumably due to the presence of endogenous ATP or an ATP-synthesizing system. The finding that rabbit-liver slices produce less 2-methoxyoestriol but more 2-hydroxyoestriol than do rat-liver slices (King, 1961) suggests that the methylase studied in these experiments is the same as that studied by Axelrod & Tomchick (1958) , as they found that rabbit liver had a much lower 0-methylating activity than rat liver.
The formation of 16-oxo-oestradiol-17P from oestriol in the liver is very small compared with that in the kidney (King, 1960) .
The absence of 6'm'-hydroxyoestriol and 6-oxooestriol was rather surprising, especially as the microsomal system used in these experiments is almost identical with that with which Mueller & Rumney (1957) obtained a high yield of 6'cc'-hydroxyoestradiol-17fl from oestradiol-17,. Moreover, Breuer, Knuppen & Schriefers (1960) have recently reported the conversion of oestriol into 6-hydroxyoestriol by rat-liver slices. In view of the large amounts of oestriol which cannot be accounted for, it is possible that small amounts of these compounds are formed but are further metabolized to undetected products. In this respect it is interesting that no 6'a'-hydroxyoestriol or 6-oxooestriol could be detected in human pregnancy urine (G. F. Marrian & R. J. B. King, unpublished results). Graubard & Pincus (1942) showed that oestrogens could be oxidized by a number of plant phenolases and this work has recently been extended by Jellinck (1960) . The virtual absence of oestriol metabolism in the absence of DPN and TPN suggests that such reactions do not occur in rat liver. SUMMARY 1. The quantitative production of 2-hydroxyoestriol and 2-methoxyoestriol has been studied with rat-liver preparations. The 2-hydroxylase requires either a reduced diphosphopyridine nucleotide-or reduced triphosphopyridine nucleotideproducing system and possibly a folic acid derivative. Adenosine triphosphate has a stimulating effect. The 2-hydroxylase is localized in the microsomal fraction.
2. The 2-hydroxylase activity is absent in homogenates of kidney, ovary and uterus. There is no sex difference in the rat-liver activity.
3. The O-methylating system requires magnesium ions, adenosine triphosphate and L-methionine. Evidence is presented that the o-methylase may be the same enzyme as that studied by Axelrod & Tomchick (1958) .
4. Preliminary evidence suggests that oestrone, 17cx-ethynyloestradiol-17 , stilboestrol and possibly oestradiol-17fl can be methoxylated in the position ortho to an existing phenolic group.
5. 16-Oxo-oestradiol-17fl and another unknown compound have been detected as minor metabolites of oestriol. The oestriol-16-hydroxy dehydrogenase is localized in the 1050OOg supernatant fraction.
6. The relationship of reduced pyridine nucleotide, folic acid and adenosine triphosphate to hydroxylation reactions has been discussed.
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